Stannous Fluoride and Its Effects on Oral Microbial Adhesive Properties in Vitro Kazuo Ota, DDS, Susumu Kikuchi, DDS, Ddsc John W

Total Page:16

File Type:pdf, Size:1020Kb

Stannous Fluoride and Its Effects on Oral Microbial Adhesive Properties in Vitro Kazuo Ota, DDS, Susumu Kikuchi, DDS, Ddsc John W PEDIATRICDENTISTRY/Copyright © 1989 by The AmericanAcademy of Pediatric Dentistry Volume1 I, NumberI Stannous fluoride and its effects on oral microbial adhesive properties in vitro Kazuo Ota, DDS, Susumu Kikuchi, DDS, DDSc John W. Beierle, PhD Abstract The effect of sodiumand stannous fluoride compoundson examined by scanning and transmission electron the coherence of Streptococcus mutans was examined. Both microscopy. commercialand reagent grade preparations were t~sted on S. In a clinical study, White and Taylor (1979) also mutans, strain 6715. Test fluoride aliquots at various reported a significant reduction in plaque from daily concentrations were added to sucrose suspensions of S. rinsing with 0.1% SnF2. Klock et al. (1985) further mutansat a starting microbial suspensionsequivalent to 25% examined the effects of twice-daily mouthrinses with transmission as read in a spectrophotometer. Test samples either SnF2 or sodium fluoride (NaF) in adults and were rotated at 35°, 80 rpmin an incubated orbital shaker. reported that after 1 year of rinsing with SnF2patients Analysis at 560 nmat various time periods, wasperformed to had fewer Streptococcus mutans/ml saliva, a lower determine increases in %T as a function of aggregate incidence of caries, and less gingivitis than those formation. SnF2 preparationsroutinely inhibited coherenceat participants rinsing with NaF. Long-term clinical concentrations as low as .001%, whereas NaF showed no studies by Leverett et al. (1986) suggested that 0.1% SnF~ effects on microbialcell-to-cell coherence. caused 4-5 times as muchextrinsic stain as 0.05% NaF after a 28-month mouthrinsing period, but there were Prevention and control of dental plaque by daily no statistically significant differences between the 2 rinsing with fluoride-containing solutions is widely fluoride groups in terms of total DMFS. used. The major efforts in fluoride mouth rinsing have Early plaque formation is considerably enhanced by been directed to treatment strategies that strengthen S. mutans species cohering to one another after adhering enamel or affect cariogenic bacteria. Although these to a tooth surface. The cohesion-adhesion is at least fluoride effects traditionally have been considered to be partly due to glucan production and its coating of cells mainly the result of a physiochemical interaction with after sucrose utilization. These substances act as part of enamel, there is evidence that fluoride also alters the biological "glue" enhancing bacterial adherence. bacterial metabolism at low concentrations, and is Levan and other microbial components may also play a bacteriocidal at higher concentrations (Loesche et al. part in bacteria-to-bacteria binding. 1975; Hamilton 1977). Therefore, the comparative The purpose of this study was to investigate qualities of various fluoride complexes on the oral stannous fluoride complexes on oral microbial adhesive microbial ecosystem has been a topic of interest over the properties and also to compare the stannous and the years. sodium ion forms of fluoride compounds. Konig (1959) studied the effects of topically administered stannous fluoride on the accumulation of Materials and Methods plaque on rat molars in vivo. Not only was enamel Bacterial cultures of S. mutans, strain 6715, solubility and caries reduced, but extensive plaque (American Type Culture Collection [ATCC]25175, Lot inhibition was noted as well. Tinanoff et al. (1976) 0585 S) were inoculated into a nutrient broth made of further showed that there is more suppression of tryptose phosphate broth and Todd Hewitt broth 2:1 by bacterial colonization on enamel by SnF2 than by NaF volume and incubated 16-20 hr at 35° C. The bacterial with mouthrinses at a concentration of 100 ppm F-, in cultures then were centrifuged at 3000 rpm x g for 10 vivo. Mouthrinsing was performed either once or twice rain, after which the supernatant was decanted from the a day for up to 7 days. The enamel specimens were Pediatric Dentistry: March,1989 N Volume11, Number1 21 solid pellet The pellet was mixed in a saline wash and time to determine characteristics of effects of fluoride- centrifuged again for 10 min to remove residual spent containing solutions on the aggregation of S. mutans media. All test and control solutions were maintained at (Fig 1). 2pH 4.0 in phthalate buffer. This pH was used since SnF Other aggregation assays were performed using was found not to autoprecipitate in the experimental chemically pure fluoride reagents in addition to the time sequences required and microbial adherence was commercial product mixtures, ACTand Gel-Kam. The noted to be well promoted within the pH range 4.0-6.0 aggregation analyses usually were completed by 90 min (Beierle et al. 1979). A volumeof a 1.0% sucrose in 0.05 at which time maximumcohesion was sustained. M phthalate buffer, pH 4.00 solution was added to the pellet which was resuspended to a concentration 120. equivalent to 25%transmittance in a spectrophotometer (Model DB -- Beckman; Irvine, CA) at 560 nm. Gel- 100 Kam® (Scherer Lab Inc; Dallas, TX) was selected representative of a stannous fluoride-containing 80- product and ACT® (Johnson & Johnson Products Inc; New Brunswick, NJ) as a representative of a sodium 60- fluoride-containing product. The SnF2 rinse (Gel-Kam) was diluted with pH 4.00 phthalate buffer solution (1:3) 40- immediately before use to produce a stock 0.1% solution. The NaF mouthrinse (ACT) was used as 20- stock solution at a concentration of 0.05%. These starting stock solutions were used in testing as 0 ~ ~o 4’s ~o 7~ ~’o ~o 11o no interfering precipitation occurred in controls minutes analyzed for the required 120 min necessary to complete ¯ 1.0 % SUCROSE the analyses. A 4.5-mi aliquot of the 25%T bacterial ....... ~,~....... 0.005% NaF ( ACT ~ ÷ SUCROSE suspension made up in sucrose was added to 60 x 15- ...... "~ ........ 0.01 ~ SnF2 ( Gel - Kam) ¯ SUCROSE mmplastic Petri dishes (#1007 -- Falcon Plastics; ~~ SALINE Oxnard, CA) and 0.5 ml aliquots of each fluoride- FIG1. Aggregationprofiles of S. mutansin the presenceof sucrose, containing solution then were added to make a final saline, and fluoride preparations. volume of 5.0 ml. Varying dilutions of fluoride were made up to final concentrations from 0.01 to 0.005%. All 1.0% sucrose test solutions were adjusted to a pH of 4.00 with 0.005% NaF(ACT) + sucrose phthalate buffer. Control 25%T suspensions of bacteria 0.01% SnF2 (Gel-Kam)+ sucrose without fluoride additives were analyzed in 1% sucrose Saline solutions or in with 0.85%saline solutions. The test Petri dishes were then rotated in a gyratory shaker (Model Results GS-8 -- New Brunswick Environmental Shaker; New ° The coherence of S. mutans is greatly enhanced in the Brunswick, NJ) at 80 rpm at 35 C. presence of sucrose compared to that of saline (Fig 1). Triplicate samples of each group were analyzed in a Coherence was noted to start rapidly and the adherence spectrophotometer to assess bacterial aggregation at assays generally were completed at the end of 1 hr. The time points ranging from 0 to 120 min. All experiments addition of ACT solution containing 0.005% NaF were performed a minimumof 3 separate times in order showed no substantial differences over that of the to substantiate findings. sucrose control aggregation assay. The addition of Gel- This aggregation assay is based on the detection of Kam containing 0.01% SnF2, however, did reveal a increased percentage of transmission as a function of significant reduction in the ability of S. mutansto cohere. increased microbial cohesion (Beierle et al. 1979). Photographs of the various aggregates detected after The highest percentage of transmissions obtained 60 rain in Figure 1 show the various coherent masses was arbitrarily set to 100%and all other values then (Figs 2a-d). The aggregates of S. mutans shaken in were corrected to 100%T as well, with a starting point of sucrose consistently were viewed as being compact, 0%T. Actually, all test samples started at 25%T which rounded, and distinctly visible, ranging from 1 to 2 mm allowed for adequate microbial numbers for coherence in diameter (Fig 2a). Whencompared to samples rotated to occur in the rotary suspension shaking procedure. in saline (Fig 2b) the plates were seen to contain turbid, The mean value and standard deviation were milky suspensions of nonaggregated bacteria. When calculated and plotted as corrected percentage of T vs. these viable suspensions were viewed at 630x 22 EH:ECT OF .SNF2 ON .S. MUTANS:Ota et al. Again, no inhibition of cohesion of S. mutans was noted, even at concentrations higher than that found in stock solutions of ACT. Interestingly, S. mutans was continually noted to adhere slightly better in sucrose solutions in all concentrations tested ranging from IO'1 to lQ-8% NaF. Similar experiments were performed with Gel-Kam containing SnF, to determine if any differences existed when using the stannous vs. the sodium form of fluoride compound. The Gel-Kam preparation demon- strated reduction in coherence at SnF, concentrations as low as 0.001% (Fig 5, next page). This finding contrasted sharply with the lack of effect detected in a01% SnFi (Q«l-K«n)+ SUCROSE preparations using NaF (Figs 3,4). When reagent grade SnF2 was FIG 2. Aggregates of S. mutans at 60 min exposed to various reagents. utilized in place of the Gel-Kam preparation, similar effects on magnification by polarized light or interference cohesion in the same concentration range were noted microscopy the streptococci were found to be mainly in (Fig 6, next page). single cell suspension or in pairs. Bacteria rotated in saline barely cohered past that noted at the initial time Discussion of dispersion. The process of adherence of oral microbes to enamel Starting cultures were dispersed by vigorous surfaces or to various dental materials is of considerable agitation on a vortex mixer followed by trituration interest (Fujioka et al.
Recommended publications
  • United States Patent Office Patented Sept
    3,000,702 United States Patent Office Patented Sept. 19, 196 2 since potassium fluoride is very soluble. In this case, a 3,000,702 MANUEFACTURE OF SODIUM FLUOR DE double or complex salt is formed in the melt between George L. Cunningham, Burtonsville, Md., assignor to potassium fluoride and the calcium salt and that is slowly W. R. Grace & Co., New York, N.Y., a corporation extracted with water in spite of the great solubility of of Connecticut potassium fluoride in water. The corrosion of the molten No Drawing. Filed May 23, 1958, Ser. No. 737,196 melt is also a considerable problem although suitable 4. Claims. (CI. 23-88) ceramic materials have been discovered for constructing the fusion vessel. This invention relates to a process for the manufac Processes have been devised for the production of so ture of sodium fluoride relatively low in silica content. 10 dium fluoride based on the thermal decomposition of More particularly, this invention relates to a cyclic proc sodium silicofluoride to sodium fluoride and silicon tetra ess whereby sodium fluoride, relatively low in silica con fluoride (U.S. 1,896,697, U.S. 2,588,786, 1,730,915, tent and ammonium chloride, may be manufactured from 2,602,726, and U.S. 1,664,348). These processes are cheap and readily available raw materials. faulty in that relatively high temperatures are required to As manufactured at the present time, technical sodium 15 decompose the sodium silicofluoride and thus it is very fluoride contains 94% to 97% NaF and 1.5% to 5.0% difficult to carry the reaction to completion.
    [Show full text]
  • Clinical and Microbiological Study
    J Clin Exp Dent. 2015;7(5):e569-75. Combined mouthrinse in orthodontics Journal section: Oral Medicine and Pathology doi:10.4317/jced.51979 Publication Types: Research http://dx.doi.org/10.4317/jced.51979 Combined chlorhexidine-sodiumfluoride mouthrinse for orthodontic patients: Clinical and microbiological study Mahboobe Dehghani 1, Mostafa Abtahi 2, Hamed Sadeghian 3, Hooman Shafaee 1, Behrad Tanbakuchi 4 1 Assistant professor of orthodontics, Dental research center, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran 2 Associate professor of orthodontics, Dental research center, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran 3 Pathologist, Department of general Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran 4 Assistant professor of orthodontics, Department of orthodontics, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran Correspondence: Mostafa Abtahi Dental Research Center School of Dentistry Dehghani M, Abtahi M, Sadeghian H, Shafaee H, Tanbakuchi B. Com-Com- Mashhad University of Medical Sciences bined chlorhexidine-sodiumfluoride mouthrinse for orthodontic patients: Park Square, Vakilabad Blvd., Mashhad, Iran Clinical and microbiological study. J Clin Exp Dent. 2015;7(5):e569-75. [email protected] http://www.medicinaoral.com/odo/volumenes/v7i5/jcedv7i5p569.pdf Article Number: 51979 http://www.medicinaoral.com/odo/indice.htm © Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488 Received: 24/08/2014 eMail: [email protected] Accepted: 11/12/2014 Indexed in: Pubmed Pubmed Central® (PMC) Scopus DOI® System Abstract Background: Orthodontic appliances impede good dental plaque control by brushing. Antimicrobial mouth rinses were suggested to improve this performance. We therefore aimed to investigate the effects of combined mouthrinse containing chlorhexidine (CHX) and sodium fluoride (NaF) on clinical oral hygiene parameters,and plaque bacte- rial level.
    [Show full text]
  • Co-Operative Effect of Exogenous Dextranase and Sodium Fluoride On
    Journal of Dental Sciences (2016) 11,41e47 Available online at www.sciencedirect.com ScienceDirect journal homepage: www.e-jds.com ORIGINAL ARTICLE Co-operative effect of exogenous dextranase and sodium fluoride on multispecies biofilms Yuan-xin Qiu a,b,cy, Meng-ying Mao a,by, Dan Jiang d, Xiao Hong a,b, Ying-ming Yang a,b, Tao Hu a,b* a Department of Preventive Dentistry, State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China b Department of Operative Dentistry and Endodontics, State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China c Department of Operative Dentistry and Endodontics, Tianjin Stomatological Hospital, Tianjin, China d Department of Operative Dentistry and Endodontics, The Affiliated Hospital of Stomatology, Chongqing Medical University, Chongqing, China Received 22 June 2015; Final revision received 4 August 2015 Available online 21 November 2015 KEYWORDS Abstract Background/purpose: The co-operative effect of exogenous dextranase (Dex) and confocal laser sodium fluoride (NaF) on Streptococcus mutans monospecies biofilms is impressive. Here we scanning investigated the effects of the combination on a mature cariogenic multispecies biofilm and microscopy; analyzed the potential mechanism. dextranase; Materials and methods: A multispecies biofilm of S. mutans, Lactobacillus acidophilus,and multispecies Actinomyces viscosus was established in vitro. Dex and NaF were added separately or cariogenic biofilm; together. The effects of the agents on the biomass were measured. The exopolysaccharide sodium fluoride; production was determined with the scintillation counting method. The viability and viability value morphology were evaluated using colony forming unit and confocal laser scanning micro- scopy, respectively.
    [Show full text]
  • Retention of Long-Term Interim Restorations with Sodium Fluoride Enriched Interim Cement Carolyn Strash Marquette University
    Marquette University e-Publications@Marquette Master's Theses (2009 -) Dissertations, Theses, and Professional Projects Retention Of Long-Term Interim Restorations With Sodium Fluoride Enriched Interim Cement Carolyn Strash Marquette University Recommended Citation Strash, Carolyn, "Retention Of Long-Term Interim Restorations With Sodium Fluoride Enriched Interim Cement" (2013). Master's Theses (2009 -). Paper 201. http://epublications.marquette.edu/theses_open/201 RETENTION OF LONG-TERM INTERIM RESTORATIONS WITH SODIUM FLUORIDE ENRICHED INTERIM CEMENT by Carolyn Strash, D.D.S. A Thesis submitted to the Faculty of the Graduate School, Marquette University, in Partial Fulfillment of the Requirements for the Degree of Master of Science Milwaukee, Wisconsin May 2013 ABSTRACT RETENTION OF LONG-TERM INTERIM RESTORATIONS WITH SODIUM FLUORIDE ENRICHED INTERIM CEMENT Carolyn Strash, DDS Marquette University, 2013 Purpose: Interim fixed dental prostheses, or “provisional restorations”, are fabricated to restore teeth when definitive prostheses are made indirectly. Patients undergoing extensive prosthodontic treatment frequently require provisionalization for several months or years. The ideal interim cement would retain the restoration for as long as needed and still allow for ease of removal. It would also avoid recurrent caries by preventing demineralization of tooth structure. This study aims to determine if adding sodium fluoride varnish to interim cement may assist in the retention of interim restorations. Materials and methods: stainless steel dies representing a crown preparation were fabricated. Provisional crowns were milled for the dies using CAD/CAM technology. Crowns were provisionally cemented onto the dies using TempBond NE and NexTemp provisional cements as well as a mixture of TempBond NE and Duraphat fluoride varnish. Samples were stored for 24h then tested or thermocycled for 2500 or 5000 cycles before being tested.
    [Show full text]
  • Drug Prescribing for Dentistry Dental Clinical Guidance
    Scottish Dental Clinical Effectiveness Programme SDcep Drug Prescribing For Dentistry Dental Clinical Guidance Second Edition August 2011 Scottish Dental Clinical Effectiveness Programme SDcep The Scottish Dental Clinical Effectiveness Programme (SDCEP) is an initiative of the National Dental Advisory Committee (NDAC) and is supported by the Scottish Government and NHS Education for Scotland. The programme aims to provide user-friendly, evidence-based guidance for the dental profession in Scotland. SDCEP guidance is designed to help the dental team provide improved care for patients by bringing together, in a structured manner, the best available information that is relevant to priority areas in dentistry, and presenting this information in a form that can interpreted easily and implemented. ‘Supporting the dental team to provide quality patient care’ Scottish Dental Clinical Effectiveness Programme SDcep Drug Prescribing For Dentistry Dental Clinical Guidance Second Edition August 2011 Drug Prescribing For Dentistry © Scottish Dental Clinical Effectiveness Programme SDCEP operates within NHS Education for Scotland. You may copy or reproduce the information in this document for use within NHS Scotland and for non-commercial educational purposes. Use of this document for commercial purpose is permitted only with written permission. ISBN 978 1 905829 13 2 First published 2008 Second edition published August 2011 Scottish Dental Clinical Effectiveness Programme Dundee Dental Education Centre, Frankland Building, Small’s Wynd, Dundee DD1
    [Show full text]
  • United States Patent (19) 11 Patent Number: 4,828,822 Miihlemann Et Al
    United States Patent (19) 11 Patent Number: 4,828,822 Miihlemann et al. (45) Date of Patent: May 9, 1989 (54) PROCESS FOR STABILIZING AQUEOUS S. Ebell, "Karies und Zuckeraustauschstoffe', Emah COMPOSITIONS CONTAINING T N SALTS rungsclorschung Hett, 1978, pp. 171-174. 75) Inventors: Hans R. Miihlemann, Zollikon; Hans H. R. Muhlemann, "Zuckerfreie, Zahnschonende und Schmid, Muttenz, both of Nicht-Kariogene Bonbons und Sussigkeiten'. Switzerland 88, Scand J. Dent. Res., 193-200 (1980), “Effect of Mouthrinses With Tin(II), Fluoride, Lanthanum Chlo 73) Assignee: GABA International AG, Basel, ride, Sodium Fluoride and Chlorohexidine on the Switzerland Amount of Lipoteichoic Acid Formed in Plaque'. (21) Appl. No.: 109,830 Substitution of Sucrose by Lycasin in Candy, Roslagen Study, Frostell et al., Acta Odontol. Scand., 1974, 32(4), 22 Filed: Oct. 16, 1987 235-54 (Eng), 71769m, CA 82-71769. Chemical Abstract, 80-128408h, Effect of Mouth Related U.S. Application Data Rinses with Sucrose, Glucose, Fructose, Lactose, Sor 63 Continuation-in-part of Ser. No. 363,013, Mar. 29, bitol, and Lycasin on the pH of Dental Plaque. 1982, abandoned, which is a continuation of Ser. No. Chemical Abstracts, 93-106820c, Effect of Inorganic 192,874, Oct. 1, 1980, abandoned. Ions and Surface Active Organic Compounds on the (30) Foreign Application Priority Data Adherence of Oral Streptococci. Oct. 2, 1979 GB United Kingdom ................. 7934159 Chemical Abstract, 93:43218q, Relation of Amylase to Starch and Lycasin Metabolism in Human Dental Jan. 24, 1980 GB United Kingdom ................. 8002433 Plaque in Vitro. Feb. 1, 1980 GB United Kingdom ................. 8003525 Fed. Reg. 17,245(1974).
    [Show full text]
  • Sodium Fluoride Jtbaker.Pdf
    MSDS Number: S3722 * * * * * Effective Date: 03/14/11 * * * * * Supersedes: 09/23/09 SODIUM FLUORIDE 1. Product Identification Synonyms: Floridine; sodium monofluoride; disodium difluoride; natrium fluoride; Florocid CAS No.: 7681-49-4 Molecular Weight: 41.99 Chemical Formula: NaF Product Codes: J.T. Baker: 3687, 3688, 3689 Macron: 0467, 5309, 5325, 7636 2. Composition/Information on Ingredients Ingredient CAS No Percent Hazardous --------------------------------------- ------------ ------------ --------- Sodium Fluoride 7681-49-4 100% Yes 3. Hazards Identification Emergency Overview -------------------------- DANGER! MAY BE FATAL IF SWALLOWED OR INHALED. AFFECTS RESPIRATORY SYSTEM, HEART, SKELETON, CIRCULATORY SYSTEM, CENTRAL NERVOUS SYSTEM AND KIDNEYS. CAUSES IRRITATION TO SKIN, EYES AND RESPIRATORY TRACT. IRRITATION EFFECTS MAY BE DELAYED. SAF-T-DATA(tm) Ratings (Provided here for your convenience) ----------------------------------------------------------------------------------------------------------- Health Rating: 3 - Severe (Poison) Flammability Rating: 0 - None Reactivity Rating: 1 - Slight Contact Rating: 3 - Severe Lab Protective Equip: GOGGLES & SHIELD; LAB COAT & APRON; VENT HOOD; PROPER GLOVES Storage Color Code: Blue (Health) ----------------------------------------------------------------------------------------------------------- Potential Health Effects ---------------------------------- If inhaled or swallowed, this compound can cause fluoride poisoning. Early symptoms include nausea, vomiting, diarrhea, and weakness.
    [Show full text]
  • Sodium Fluoride-Induced Oxidative Stress and Histological Changes in Liver of Swiss Albino Mice and Amelioration by Ocimum Sanctum Linn
    Online - 2455-3891 Vol 11, Issue 9, 2018 Print - 0974-2441 Research Article SODIUM FLUORIDE-INDUCED OXIDATIVE STRESS AND HISTOLOGICAL CHANGES IN LIVER OF SWISS ALBINO MICE AND AMELIORATION BY OCIMUM SANCTUM LINN. BHAGWENDRA PRAKASH, SURESH KUMAR SABAL, RAJBALA VERMA, JOHN PJ, INDERPAL SONI* Department of Zoology, Environmental Toxicology Laboratory, Centre for Advanced Studies, University of Rajasthan, Jaipur, Rajasthan, India. Email: [email protected]; [email protected] Received: 20 April 2018, Revised and Accepted: 19 May 2018 ABSTRACT Objective: The present study was designed to evaluate hepatotoxicity induced by sodium fluoride (NaF) in Swiss albino mice and amelioration by Ocimum sanctum Linn. Methods: Mice were divided into six groups, Group I received tap water, Group II received low dose of NaF (8 mg/L), Group III high dose of NaF (80 mg/L) in drinking water, Group IV tap water along with 250 mg/kg body weight/day leaf extract of O. sanctum Linn., Group V 8 mg/L NaF in drinking water and 250 mg/kg body weight leaf extract of O. sanctum Linn., and Group VI 80 mg/L NaF in drinking water along with leaf extract of O. sanctum Linn. 250 mg/kg body weight/day for 90 days. On the 91st day, the animals were autopsied and liver tissue samples were taken to assess histopathological changes and oxidative stress by estimating glutathione peroxidase, superoxide dismutase, and catalase. Results: A highly significant decrease in the activity of antioxidant enzymes occurred with the high dose (Group III). Hepatic histopathological architecture exhibited deformities, namely, ballooning, hypertrophy, hepatocellular necrosis, infiltration of mononuclear cells, deformed central vein, sinusoidal dilation, and binucleated cells.
    [Show full text]
  • Selected Medicines Used in Iontophoresis
    pharmaceutics Review Selected Medicines Used in Iontophoresis Tomasz M. Karpi ´nski Department of Medical Microbiology, Pozna´nUniversity of Medical Sciences, Wieniawskiego 3, 61-712 Pozna´n,Poland; [email protected] or [email protected]; Tel.: +48-61-854-61-38 Received: 19 September 2018; Accepted: 24 October 2018; Published: 25 October 2018 Abstract: Iontophoresis is a non-invasive method of systemic and local drug delivery using an electric field. Iontophoresis enables diffusion of the selected drug via skin, mucosa, enamel, dentin, and other tissues. The amount of delivered therapeutic molecules is about 10–2000 times greater than conventional forms of delivery. Among other fields, this method is used in dentistry, ophthalmology, otorhinolaryngology, and dermatology. According to related literature, the most important drugs studied or administered by iontophoresis are: Local anesthetics, opioids, steroids, non-steroidal anti-inflammatory drugs, antibacterial drugs, antifungal drugs, antiviral drugs, anticancer drugs, fluorides, and vitamins. The present review covers current available data regarding the selected medicines used in iontophoresis. Furthermore, indications and conditions of iontophoresis application are reviewed. Keywords: iontophoresis; drug delivery; dentistry; ophthalmology; local anaesthetics; non-steroid anti-inflammatory drugs; antibiotics; anticancer drugs 1. Introduction Iontophoresis is a type of electrotherapy, during which a drug is introduced deep into the tissues as a means of systemic and local drug application [1]. It is based on the principle that in a given electric field, positively charged drug ions (cations) are repelled by a positive electrode (anode) and are directed to the cathode (Figure1). In turn, negative ions (anions, e.g., ketoprofen) being repelled by the negative electrode (cathode), follow the anode.
    [Show full text]
  • Prescription Drug Program Formulary Effective July 1, 2008
    PRESCRIPTION DRUG PROGRAM FORMULARY EFFECTIVE JULY 1, 2008 www.MyIBXTPA.com a b Dear Participant: In an effort to continue our commitment to provide you with comprehensive prescription drug coverage, a formulary feature is included in your prescription drug benefit. A formulary is a list of selected FDA-approved prescription medications reviewed by the Pharmacy and Therapeutics Committee. These prescription medications have been selected for their reported medical effectiveness, safety, and value, while providing you with the highest level of coverage under your prescription program. The following information serves as a guide when reviewing the list of formulary drugs on the following pages. • Bolded drug = Formulary generic available at lowest copay • Non-bolded drug = Formulary brand available at middle copay • Drug in parenthesis ( ) = Non-formulary brand drug available at the highest copay. It is displayed next to the equivalent formulary generic Drug that is available at the lowest copay. For example: amoxicillin is the formulary generic drug available at the lowest copay. (Amoxil) is the non-formulary brand available at the highest copay. In most cases when brand drugs have a generic equivalent, the generic version is formulary and the brand version is non-formulary. • Covered brand drugs not listed are non-formulary and are available at the highest copay. The above information is highlighted in a key box indicated on every other page of the formulary list. Our pharmacy benefits manager, FutureScripts®, continuously monitors effectiveness and safety of drugs and drug prescribing patterns. 1 Please note: Because prescription drug programs vary by group, the inclusion of a drug in this formulary does not imply coverage.
    [Show full text]
  • Influence of Eugenol-Based Materials and Cleaning Procedures Previously
    Lopes et al. Appl Adhes Sci (2016) 4:15 DOI 10.1186/s40563-016-0072-6 RESEARCH Open Access Influence of eugenol‑based materials and cleaning procedures previously to resin composite restoration on microleakage after 1‑year storage Murilo Baena Lopes1* , Klissia Romero Felizardo2, Renan Hideki Kaneshima1, Sandrine Berger Guiraldo1, Ricardo Danil Guiraldo1 and Alcides Gonini Júnior1 *Correspondence: [email protected] Abstract 1 School of Dentistry, The interference of eugenol on the adhesive systems and composite polymerization University of North Parana- UNOPAR, Rua Marselha, 183, could promote a higher marginal microleakage. This could be reduced by mechanical Londrina, PR 86041‑140, and chemical cleansing. The objective of this study was to evaluate the influence of the Brazil previous use of eugenol-based materials to a permanent restoration on the marginal Full list of author information is available at the end of the microleakage. The influence of mechanical cleansing associated with chemical cleans- article ing with chlorhexidine gel was also evaluated. Non-eugenol endodontic sealer and temporary material and mechanical cleansing was used as a control. Eighty bovine incisors were endodontic treated and divided into eight groups (n 10) according to the sealer, temporary material and removal method. The specimens= were temporarily restored and stored for 1 week at 37 °C and 100 % relative humidity, followed by defini- tive restoration and one-year storage at the same environment. The teeth were then sealed, immersed in silver nitrate at 50 % for 2 h and sectioned to have the microleak- age qualitatively and quantitatively visually analyzed under a stereomicroscope at 45 . The percentage data were submitted to an ANOVA and Tukey’s test, and the scores × were submitted to a Kruskal–Wallis and Dunn’s test at 5 % of the significance level.
    [Show full text]
  • $5 Generic Medication Program Formulary
    $5 Generic Medication Program Formulary Anti-Infectives Quantity Anti-Infectives (continued) Quantity Amoxicillin 125mg Chewable Tablet 20 Penicillin VK 250mg Tablet 28 Amoxicillin 125mg/5ml Suspension (80ml) 80 Penicillin VK 250mg/5ml Suspension (100ml) 100 Amoxicillin 125mg/5ml Suspension (100ml) 100 Penicillin VK 250mg/5ml Suspension (200ml) 200 Amoxicillin 125mg/5ml Suspension (150ml) 150 Penicillin VK 500mg Tablet 28 Amoxicillin 200mg/5ml Suspension (50ml) 50 Tetracycline 250mg Capsule 60 Amoxicillin 200mg/5ml Suspension (75ml) 75 Tetracycline 500mg Capsule 60 Amoxicillin 200mg/5ml Suspension (100ml) 100 Trimethoprim and SMZ 200mg-40mg Syrup 120 Amoxicillin 250mg Capsule 30 Trimethoprim and SMZ 400mg-80mg Tablet 28 Amoxicillin 250mg/5ml Suspension (80ml) 80 Trimethoprim and SMZ DS 800mg-160mg Tablet 20 Amoxicillin 250mg/5ml Suspension (100ml) 100 Amoxicillin 250mg/5ml Suspension (150ml) 150 Cold / Flu Quantity Amoxicillin 500mg Capsule 30 Benzonatate 100mg Capsule 21 Ampicillin 250mg Capsule 28 Benzonatate 200mg Capsule 14 Ampicillin 500mg Capsule 28 Ceron Syrup 180 Cephalexin 250mg Capsule 28 Ceron-DM Syrup 180 Ciprofloxacin 250mg Tablet 20 Cyproheptadine 4mg Tablet 30 Ciprofloxacin 500mg Tablet 20 De-chlor DM Syrup 180 Clindamycin 150mg Capsule 28 Dex PC Syrup 120 Doxycycline Hyclate 50mg Capsule 30 Diphenhydramine 50mg Capsule 90 Doxycycline Hyclate 100mg Capsule 20 Dyphylline-GG 100mg-100mg/15ml Elixir 120 Doxycycline Hyclate 100mg Tablet 20 Gani-Tuss-DM 100mg-10mg/5ml Syrup 180 Fluconazole 50mg Tablet 14 Guaifenesin DM 100-10mg/5ml
    [Show full text]